News | Hemodynamic Support Devices | January 25, 2018

Circulatory Support Devices Study Shows Heart Donor Shortage, Improved Survival With VADS

This research report provides an in-depth analysis of the market in terms of revenue and emerging market trends.

Technavio Market Study Shows Donor Shortage and Improved Survival Rate

January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support devices market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the forecast period.

This research report titled “Global Circulatory Support Devices Market 2017-2021” provides an in-depth analysis of the market in terms of revenue and emerging market trends. This report also includes an up to date analysis and forecasts for various market segments and all geographical regions.

The market research analysis categorizes the global circulatory support devices market into three major product segments:

 

Global VAD market

The global VAD market is growing at a significant rate owing to its cost-effectiveness when compared to heart transplantation. Shortage of donors and improved survival rate are the major factors driving the demand for these supporting devices. VAD will provide aid to the heart but not completely replace heart activities. Also, the advances in technology in terms of design are playing a key role in higher adoption of VAD in developed countries. The growing number of patients with congestive heart failure (IV stage) is another main factor driving the sales of VADs in the global circulatory support devices market. Moreover, advances in technology have led to the development of new generation LVADs, which are small, less noisy, and durable with enhanced power sources.

 

Global ECMO market

The global ECMO market is expected to grow at a moderate rate owing to the growing incidence of cardiovascular disorders, respiratory disorders, and the growing geriatric population. In addition, the outspread application of ECMO is driving the demand through various application segments such as cardiac, respiratory, and extracorporeal cardiopulmonary resuscitation (ECPR).

“In addition, a significant rise in ECMO centers, rising awareness through conferences and training programs, and the advances in technology are significant factors driving the demand for ECMO supporting devices during the forecast period. Also, the growing older population in APAC and a significant number of people with cardiopulmonary diseases in developing nations such as China and India are expected to provide the potential growth opportunity for ECMO devices,” said Barath Palada, a lead analyst at Technavio for cardiovascular devices research.

 

Global TAH market

The global TAH market is growing at a faster rate compared with other circulatory assist devices globally. Europe is the leading revenue contributor to the global TAH market, followed by the Americas and APAC. Europe dominates the market, as the device got European Medicines Agency (EMA) approval before the U.S. FDA approval and had early adoption advantage for the end-users.

The market for TAH is expected to benefit from the fact that it is the only option, which can provide a permanent solution in the absence of a donor's heart. The TAH is gaining popularity among critically ill patients, who are in life-threatening condition due to extreme malfunction of their heart. The TAH will enhance the life expectancy of people with end-stage heart failure and extend the life expectancy over months compared with the other circulatory support devices.

The top vendors highlighted by Technavio’s market research analysts in this report are:

  • Medtronic
  • St. Jude Medical
  • Abiomed
  • ReliantHeart
  • Berlin Heart

For more information: www.technavio.com


Related Content

News | Artificial Heart

August 15, 2022 — Researchers in the Biomedical Engineering Department at UConn have developed a new cardiac cell ...

Home August 15, 2022
Home
News | Artificial Heart

July 14, 2022 — University of Toronto Engineering researchers have grown a small-scale model of a human left heart ...

Home July 14, 2022
Home
News | Artificial Heart

April 25, 2022 – There’s no safe way to get a close-up view of the human heart as it goes about its work: you can’t just ...

Home April 25, 2022
Home
News | Artificial Heart

March 28, 2022 — Carmat, the designer and developer of the world’s most advanced total artificial heart, aiming to ...

Home March 28, 2022
Home
News | Artificial Heart

June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can ...

Home June 23, 2021
Home
News | Artificial Heart

February 10, 2021 - The U.S. Food and Drug Administration (FDA) has granted artificial heart developer Carmat approval ...

Home February 10, 2021
Home
News | Artificial Heart

May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first ...

Home May 27, 2020
Home
News | Artificial Heart

March 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total ...

Home March 10, 2020
Home
News | Artificial Heart

December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life science ...

Home December 11, 2017
Home
News | Artificial Heart

October 27, 2017 — CorInnova Inc. announced it has received notice of allowance of a seminal patent to protect its ...

Home October 27, 2017
Home
Subscribe Now